Chengjun Li

Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma

Haixiong Ge, Xinghai Ning, Lei Zhang, 2020, Nano Research.

Composite reconstruction of the hip following resection of periacetabular tumors: middle-term outcome.

Xin Shi, Sujia Wu, Chengjun Li, 2013, The Journal of arthroplasty.

The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.

Jianning Zhao, Xiao-zhou Liu, Xin Shi, 2013, Frontiers in bioscience.

The progress of molecular diagnostics of osteosarcoma.

Xiao-zhou Liu, Xin Shi, Xing Zhou, 2016, Frontiers in bioscience.

Isoliquiritigenin inhibits the proliferation, apoptosis and migration of osteosarcoma cells.

Xiao-zhou Liu, Xin Shi, Xing Zhou, 2019, Oncology reports.

Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma

Junfeng Zhang, Jiangning Chen, Xin Shi, 2015, Tumor Biology.

Hypoxia Inhibitor Combined with Chemotherapeutic Agents for Antitumor and Antimetastatic Efficacy against Osteosarcoma.

Lei Xing, Tian-Jiao Zhou, Tianxiao Zhao, 2023, Molecular pharmaceutics.

Personalized Identification of Differentially Expressed Modules in Osteosarcoma

Lei Zhang, Xiaozhou Liu, Xin Shi, 2017, Medical science monitor : international medical journal of experimental and clinical research.

Neoadjuvant chemotherapy for osteosarcoma of the extremity: Outcome of the Chinese 1st protocol in a single institute

Jianning Zhao, Xin Shi, Sujia Wu, 2009 .